Calliditas Therapeutics AB (publ)
CALTX.ST
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.24B
Close$
Share Statistics
| Market cap | $11.24 Billion |
|---|---|
| Enterprise Value | $11.23 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.69 |
| Beta | 1.46 |
| Outstanding Shares | 53,686,948 |
Return
| Return on Equity | -1172.24% |
|---|---|
| Return on Assets | -1163.23% |
| Return on Invested Capital | -856.92% |
Valuation & Multiples
| P/E Ratio | -23.94 |
|---|---|
| PEG | 0.15 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1372898.18 |
| Enterprise Value to EBIT | -212.67 |
| Enterprise Value to Net Income | -156 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Calliditas Therapeutics AB
50 employees
CEO: Jonah Hicks Clara Technologies Corp. specializes in delivering IT software solutions tailored for merchants operating on Amazon. Additionally, the firm extends its expertise through professional services, guiding clients in effectively selling their...